Filing Flows

Filing Flows › Companies › Imax › Timeline

Imax stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+38.4% to $47.67

Imax (IMAX) stock rose 38% over the last 252 sessions, to $47.67. On the way it reported 4 quarters, its insiders filed 8 open-market trades and 8 Form 144 notices of planned sales, and the company filed 3 material 8-Ks. Each is marked on the price and listed with what the stock did next.

IMAX: a year of the stock with every disclosure on itIMAX: a year of the stock with every disclosure on it$37.98$44.71$51.45$58.19◆2025-11-06 · Material definitive agreement●2026-02-25 · Earnings: beat the EPS estimate by 22.9%▼2026-03-10 · Gelfond Richard L sold $4.9M▼2026-03-16 · Douglas Kevin sold $21.5M◆2026-04-17 · Directors and officers: departures, appointments, pay●2026-04-30 · Earnings: beat the EPS estimate by 10.7%●2026-07-23 · Earnings: beat the EPS estimate by 58.8%▼2026-08-06 · Zlatar Jose Aleksandr sold $25K▽2026-08-18 · Form 144: Richard Gelfond plans to sell $7.6M▽2026-08-19 · Form 144: Richard Gelfond plans to sell $11.0M▼2026-08-20 · Pablo Calamera sold $786K▽2026-08-20 · Form 144: Richard Gelfond plans to sell $5.3M▽2026-08-20 · Form 144: Pablo M Calamera plans to sell $786K◆2026-08-21 · Directors and officers: departures, appointments, pay▼2026-08-24 · Fernandes Natasha sold $1.1M▽2026-08-24 · Form 144: Natasha Fernandes plans to sell $1.1M▼2026-08-25 · Welton Mark sold $1.6M▼2026-08-25 · Weissman Kenneth Ian sold $436K▽2026-08-25 · Form 144: Mark Welton plans to sell $1.6M▽2026-08-25 · Form 144: Kenneth Weissman plans to sell $436K▼2026-09-10 · Lister Robert D sold $1.2M▽2026-09-10 · Form 144: Robert D. Lister plans to sell $1.2M●2026-11-05 · Earnings: beat the EPS estimate by 116.2%◆8-K event●Earnings report▼Insider sale▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 5, 2026EarningsEarnings: beat the EPS estimate by 116.2%−7.3% (−2.8% vs SPY)——
Sep 10, 2026Form 144Form 144: Robert D. Lister plans to sell $1.2M−0.5% (+0.1% vs SPY)+0.9% (+2.0% vs SPY)−0.6% (−2.3% vs SPY)
Sep 10, 2026Insider saleLister Robert D sold $1.2M−0.5% (+0.1% vs SPY)+0.9% (+2.0% vs SPY)−0.6% (−2.3% vs SPY)
Aug 25, 2026Form 144Form 144: Kenneth Weissman plans to sell $436K−1.6% (−2.0% vs SPY)−6.8% (−7.2% vs SPY)−2.8% (−3.6% vs SPY)
Aug 25, 2026Form 144Form 144: Mark Welton plans to sell $1.6M−1.6% (−2.0% vs SPY)−6.8% (−7.2% vs SPY)−2.8% (−3.6% vs SPY)
Aug 25, 2026Insider saleWeissman Kenneth Ian sold $436K−1.6% (−2.0% vs SPY)−6.8% (−7.2% vs SPY)−2.8% (−3.6% vs SPY)
Aug 25, 2026Insider saleWelton Mark sold $1.6M−1.6% (−2.0% vs SPY)−6.8% (−7.2% vs SPY)−2.8% (−3.6% vs SPY)
Aug 24, 2026Form 144Form 144: Natasha Fernandes plans to sell $1.1M+3.8% (+4.1% vs SPY)−4.6% (−5.1% vs SPY)+1.6% (+0.3% vs SPY)
Aug 24, 2026Insider saleFernandes Natasha sold $1.1M+3.8% (+4.1% vs SPY)−4.6% (−5.1% vs SPY)+1.6% (+0.3% vs SPY)
Aug 21, 20268-KDirectors and officers: departures, appointments, pay+3.8% (+4.1% vs SPY)−4.6% (−5.1% vs SPY)+1.6% (+0.3% vs SPY)
Aug 20, 2026Form 144Form 144: Pablo M Calamera plans to sell $786K−1.8% (−1.0% vs SPY)−1.8% (−1.4% vs SPY)−1.8% (−1.1% vs SPY)
Aug 20, 2026Form 144Form 144: Richard Gelfond plans to sell $5.3M−1.8% (−1.0% vs SPY)−1.8% (−1.4% vs SPY)−1.8% (−1.1% vs SPY)
Aug 20, 2026Insider salePablo Calamera sold $786K−1.8% (−1.0% vs SPY)−1.8% (−1.4% vs SPY)−1.8% (−1.1% vs SPY)
Aug 19, 2026Form 144Form 144: Richard Gelfond plans to sell $11.0M+6.1% (+5.8% vs SPY)+6.4% (+6.6% vs SPY)+2.5% (+3.1% vs SPY)
Aug 18, 2026Form 144Form 144: Richard Gelfond plans to sell $7.6M−3.6% (−2.9% vs SPY)+4.5% (+5.7% vs SPY)−0.6% (+1.8% vs SPY)
Aug 6, 2026Insider saleZlatar Jose Aleksandr sold $25K−1.8% (−1.6% vs SPY)+1.4% (+1.0% vs SPY)+2.5% (+2.0% vs SPY)
Jul 23, 2026EarningsEarnings: beat the EPS estimate by 58.8%+11.2% (+12.5% vs SPY)+21.4% (+23.8% vs SPY)+29.4% (+27.4% vs SPY)
Apr 30, 2026EarningsEarnings: beat the EPS estimate by 10.7%+2.1% (+1.1% vs SPY)−4.3% (−7.3% vs SPY)+6.4% (+0.2% vs SPY)
Apr 17, 20268-KDirectors and officers: departures, appointments, pay+2.4% (+2.6% vs SPY)+3.8% (+3.3% vs SPY)−2.4% (−6.3% vs SPY)
Mar 16, 2026Insider saleDouglas Kevin sold $21.5M+2.8% (+1.8% vs SPY)−3.8% (−2.0% vs SPY)−3.4% (−8.4% vs SPY)
Mar 10, 2026Insider saleGelfond Richard L sold $4.9M+0.6% (+0.7% vs SPY)−0.8% (+0.6% vs SPY)−3.3% (−3.3% vs SPY)
Feb 25, 2026EarningsEarnings: beat the EPS estimate by 22.9%−0.8% (−1.7% vs SPY)+11.2% (+12.2% vs SPY)+3.6% (+7.9% vs SPY)
Nov 6, 20258-KMaterial definitive agreement+0.2% (+0.1% vs SPY)+2.0% (+1.7% vs SPY)+11.1% (+9.2% vs SPY)

Insiders’ record here

In the year on the chart, Imax's insiders reported 0 open-market buys ($0) and 8 sales ($31.5M). Of the 2 old enough to score, 2 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −4.8%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%
2.03 New debt or off-balance-sheet obligation13,2680.0%50%+1.2%±1.3%
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Imax: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.